Diabetes prevention and care: we know what to do, so why aren't we doing it?

Stephen Colagiuri
Med J Aust 2014; 201 (9): 501-502. || doi: 10.5694/mja14.01307

Reducing the national diabetes burden

The diabetes epidemic continues unabated. Globally, 382 million people have diabetes and this is projected to increase to 592 million by 2035.1 In Australia, there are an estimated 1 million people with diabetes and another 2 million at high risk of developing diabetes.2 While the contribution of many chronic diseases to the national burden of disability is decreasing, the diabetes burden continues to increase and is predicted to become the largest contributor by 2017.3 Diabetes affects individual patients, their families and society in general, and is estimated to cost in excess of $15 billion annually.4 This burden is not shared equally, and no group is more severely affected than Australia's Indigenous population, who have higher rates of diabetes, significant premature mortality and high rates of complications, especially cardiovascular and renal disease.

Please login with your free MJA account to view this article in full

  • Stephen Colagiuri

  • Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW.

Competing interests:

No relevant disclosures.

  • 1. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149.
  • 2. Diabetes Australia. Diabetes National Election Agenda 2013-2015. (accessed Oct 2014).
  • 3. Australian Institute of Health and Welfare. Australia's health 2010. Canberra: AIHW, 2010. (AIHW Cat. No. AUS 122; Australia's Health Series No. 12.)
  • 4. Lee CM, Colagiuri R, Magliano DJ, et al. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 2013; 99: 385-390.
  • 5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
  • 6. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
  • 7. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
  • 8. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
  • 9. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
  • 10. Lindstrom J, Peltonen M, Eriksson JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2013; 56: 284-293.
  • 11. Kevat DAS, Sinha AK, McLean AG. Lower treatment targets for gestational diabetes: is lower really better? Med J Aust 2014; 201: 204-207. <MJA full text>
  • 12. d'Emden MC. Reassessment of the new diagnostic thresholds for gestational diabetes mellitus: an opportunity for improvement. Med J Aust 2014; 201: 209-211. <MJA full text>


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.